Northeastern hosted the first International Translational Nanomedicine Conference over the weekend, welcoming researchers and industry experts from around the globe.
In a new paper, Distinguished Professor Mansoor Amiji and his collaborators present a drug-delivery system they believe can specifically target only tumors and turn off the cancer cells’ “superpowers” that allow them to grow uncontrollably.
At a symposium hosted by Northeastern on Tuesday, a pioneering chemist marveled at the human body’s ability to flourish in the face of exposure to thousands of harmful pathogens.
Backed by a $2.32 million grant, pharmaceutical sciences professor Mansoor Amiji has designed a nano-cocktail that targets multi-drug resistant tumors with remarkable accuracy.
An interdisciplinary research team is developing a nanotechnology-based drug delivery system to make cancer cells more vulnerable to chemotherapy
Northeastern research teams win National Institutes of Health exploratory grants to support separate projects to develop more effective, nanotechnology-based cancer and brain-disease therapies